EULAR 2021 Revisited: Recent Updates on JAK 1,2 and IL-17 Inhibitors

Introduction

In this lecture, Prof. Bruce Kirkham and Prof. Gerd Burmester will review and discuss the scientific data recently disclosed at EULAR 2021.

Objectives

1. Review/summarize the key scientific data disclosures presented at EULAR 2021 across Rheumatology (Rheumatoid and Spondylarthritis)
2.Provide an opportunity for HCPs who attended and those who where unable to attend EULAR 2021 to discuss key scientific data and the clinical implications with subject matter experts.

This Course For :

Physician ( Allergy and immunology , Dermatology , Rheumatology )
Resident / Fellow ( Allergy and immunology , Dermatology , Rheumatology )

Speaker

Sponsored by :

Price

Course Fee

FREE

FREE
See Registration Policies, Cancellations & Refunds

Contact Information

Organization : Virtual Medical Academy
Phone : 920008161
Email : [email protected]

  • 21 Sep 2021    To    28 Sep 2021
  • 08:30 PM  To  11:59 PM
  • Certificate Available
  • Online Recorded
  • 284
  Add to Calendar 09/21/2021 08:30 PM 09/28/2021 11:59 PM Asia/ Riyadh EULAR 2021 Revisited: Recent Updates on JAK 1,2 and IL-17 Inhibitors EULAR 2021 Revisited: Recent Updates on JAK 1,2 and IL-17 Inhibitors https://medicalacademy.org/portal/event/view/1566
EULAR 2021 Revisited: Recent Updates on JAK 1,2 and IL-17 Inhibitors